[32] was the first to demonstrate a significant lower risk for major adverse liver and cardiac outcomes in the bariatric surgery group compared with nonsurgical management in patients with biopsy-proven NASH and obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] Yeh K.-.C., Yeh T.-.K., Huang C.-.Y., Hu C.-.B., Wang M.-.H., Huang Y.-.W., et al
However, individual responses vary based on genetics, diet, exercise, and underlying metabolic health, which is why PlexusDx offers personalized assessment through genetic testing
Always use the specified diluent to maintain compound integrity
The lipid mixture prevented cirrhosis in animal experiments, and it opposed fibrosis and improved liver function tests among heavy-drinking human clinical trial participants (Lieber 2004
While tirzepatide can improve cardiometabolic risk factors such as weight, blood pressure, and lipid profiles, the concurrent use of anabolic steroids may counteract these improvements and compound overall cardiovascular risk, particularly in individuals with pre-existing heart disease or multiple risk factors